Earnings calendar/ZVRA
Zevra Therapeutics, Inc. (ZVRA)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 4, 2026
Consensus estimate row
EPS target
$0.14
Street estimate
Revenue target
$37.1M
Street estimate
Trailing EPS (avg 4Q)
$0.23
Beat rate last 4: 100%
Latest EPS YoY
-88.4%
vs 2025-08-12
Latest revenue YoY
+53.3%
How results look so far
Trailing revenue (avg 4Q)
$34.0M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS beat
EPS actual / est
$0.14 / $0.11
+27.3%
Revenue actual / est
$39.7M / $33.9M
+17.1%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/4/2026upcoming | $0.14 | Pending | — | $37.1M | Pending | — |
| 8/5/2026 | $0.11 | $0.14 | +27.3% | $33.9M | $39.7M | +17.1% |
| 5/12/2026upcoming | $0.06 | Pending | — | $32.0M | Pending | — |
| 5/6/2026 | $0.06 | $0.60 | +900.0% | $32.0M | $36.2M | +13.3% |
| 3/10/2026upcoming | $0.05 | Pending | — | $28.1M | Pending | — |
| 3/9/2026 | $0.05 | $0.21 | +316.7% | $28.1M | $34.1M | +21.6% |
| 11/5/2025 | $-0.02 | $-0.01 | +50.0% | $26.6M | $26.1M | -2.2% |
| 8/12/2025 | $2.19 | $1.21 | -44.7% | $24.5M | $25.9M | +5.6% |
| 5/13/2025 | $-0.21 | $-0.06 | +71.4% | $21.1M | $20.4M | -3.2% |
| 3/11/2025 | $-0.39 | $-0.67 | -71.8% | $16.7M | $12.0M | -27.7% |
| 11/12/2024 | $-0.44 | $-0.69 | -56.8% | $8.8M | $3.7M | -57.9% |
| 8/13/2024 | $-0.47 | $-0.48 | -2.1% | $4.4M | $4.4M | +2.0% |
| 5/8/2024 | $-0.49 | $-0.40 | +18.4% | $4.7M | $3.4M | -26.3% |
| 3/28/2024 | $-0.20 | $-0.40 | -100.0% | $11.7M | $13.2M | +12.6% |
| 11/7/2023 | $-0.29 | $-0.40 | -37.9% | $10.9M | $2.9M | -73.6% |
| 8/14/2023 | $-0.39 | $-0.15 | +61.5% | $3.0M | $8.5M | +179.5% |
| 5/15/2023 | $-0.26 | $-0.34 | -30.8% | $2.6M | $2.9M | +8.6% |
| 3/7/2023 | $-0.21 | $-0.26 | -23.8% | $3.1M | $2.3M | -25.3% |
| 11/9/2022 | $-0.13 | $-0.19 | -46.2% | $3.0M | $2.9M | -4.6% |
| 8/11/2022 | $-0.12 | $-0.70 | -483.3% | $1.7M | $1.3M | -25.6% |
| 5/12/2022 | $-0.05 | $-0.05 | 0.0% | $3.1M | $4.0M | +29.4% |
| 3/30/2022 | $-0.07 | $-0.08 | -14.3% | $2.2M | $2.6M | +15.5% |
| 11/10/2021 | $-0.07 | $-0.05 | +28.6% | — | $2.0M | — |
| 8/12/2021 | $0.23 | $0.21 | -8.7% | — | $12.0M | — |
| 5/13/2021 | $-0.17 | $-0.54 | -217.6% | — | $12.1M | — |
| 3/11/2021 | $-0.64 | $-1.07 | -67.2% | — | $2.4M | — |
| 10/29/2020 | $-0.80 | $-0.64 | +20.0% | — | $1.9M | — |
| 8/12/2020 | — | $0.16 | — | — | $6.9M | — |
| 5/12/2020 | $0.16 | $-1.76 | -1200.0% | — | $2.1M | — |
| 2/28/2020 | $-1.36 | $-0.16 | +88.2% | — | $1.4M | — |
| 11/14/2019 | $-2.99 | $0.96 | +132.1% | — | $11.5M | — |
| 8/13/2019 | $-6.80 | $-5.28 | +22.4% | — | Pending | — |
| 5/14/2019 | $-7.36 | $-7.36 | 0.0% | — | Pending | — |
| 2/28/2019 | $-8.44 | $-3.20 | +62.1% | — | Pending | — |
| 11/8/2018 | $-12.32 | $-15.04 | -22.1% | — | Pending | — |
| 8/9/2018 | $-15.42 | $-14.56 | +5.6% | — | Pending | — |
| 5/10/2018 | $-11.16 | $-28.32 | -153.8% | — | Pending | — |
| 3/29/2018 | $-10.96 | $-11.52 | -5.1% | — | Pending | — |
| 11/9/2017 | $-10.76 | $-10.88 | -1.1% | — | Pending | — |
| 8/10/2017 | $-10.08 | $-7.04 | +30.2% | — | Pending | — |
| 5/10/2017 | $-10.08 | $-13.44 | -33.3% | — | Pending | — |
| 3/9/2017 | $-11.15 | $-10.88 | +2.4% | — | Pending | — |
| 11/9/2016 | $-10.03 | $-14.72 | -46.8% | — | Pending | — |
| 8/10/2016 | $-12.00 | $-9.28 | +22.7% | — | Pending | — |
| 5/12/2016 | $-7.84 | $-3.20 | +59.2% | — | Pending | — |
| 3/10/2016 | $-8.05 | $-10.24 | -27.2% | — | Pending | — |
| 11/12/2015 | $-6.72 | $-10.88 | -61.9% | — | Pending | — |
| 8/13/2015 | $-6.67 | $-39.20 | -487.7% | — | Pending | — |
| 5/27/2015 | $-7.47 | $-40.00 | -435.5% | — | Pending | — |
| 4/15/2015 | — | $-15.39 | — | — | Pending | — |
| 9/30/2014 | — | $-14.60 | — | — | Pending | — |
| 6/30/2014 | — | $-7.31 | — | — | Pending | — |
| 3/31/2014 | — | $-3.90 | — | — | Pending | — |
| 12/31/2013 | — | $-12.37 | — | — | Pending | — |
Need ZVRA data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.